Literature DB >> 20023377

Foxo1 in hepatic lipid metabolism.

Zhiyong Cheng, Morris F White.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023377     DOI: 10.4161/cc.9.2.10567

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

1.  The Foxo1-Inducible Transcriptional Repressor Zfp125 Causes Hepatic Steatosis and Hypercholesterolemia.

Authors:  Gustavo W Fernandes; Barbara M L C Bocco; Tatiana L Fonseca; Elizabeth A McAninch; Sungro Jo; Lattoya J Lartey; InSug O-Sullivan; Terry G Unterman; Nailliw Z Preite; Robin M Voigt; Christopher B Forsyth; Ali Keshavarzian; Richárd Sinkó; Allison B Goldfine; Mary E Patti; Miriam O Ribeiro; Balázs Gereben; Antonio C Bianco
Journal:  Cell Rep       Date:  2018-01-09       Impact factor: 9.423

2.  Isotretinoin and FoxO1: A scientific hypothesis.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 3.  Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.

Authors:  Zhiyong Cheng; Morris F White
Journal:  Antioxid Redox Signal       Date:  2010-09-16       Impact factor: 8.401

4.  α-Lipoic acid protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance through increasing phosphorylation of IRS-1 and Akt.

Authors:  Yu-mei Wang; Xiao-fei Lin; Chun-mei Shi; Lan Lu; Zhen-Ying Qin; Guan-zhong Zhu; Xin-guo Cao; Chen-bo Ji; Jie Qiu; Xi-rong Guo
Journal:  J Bioenerg Biomembr       Date:  2012-04-21       Impact factor: 2.945

5.  kNOXing on the door of selective insulin resistance.

Authors:  Zhiyong Cheng; Morris F White
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05       Impact factor: 8.311

Review 6.  Insulin signaling meets mitochondria in metabolism.

Authors:  Zhiyong Cheng; Yolanda Tseng; Morris F White
Journal:  Trends Endocrinol Metab       Date:  2010-07-16       Impact factor: 12.015

Review 7.  Integrating metabolism and longevity through insulin and IGF1 signaling.

Authors:  Marianna Sadagurski; Morris F White
Journal:  Endocrinol Metab Clin North Am       Date:  2012-12-21       Impact factor: 4.741

8.  Targeting FoxO1 with AS1842856 suppresses adipogenesis.

Authors:  Peng Zou; Longhua Liu; Louise Zheng; Lu Liu; Rebecca E Stoneman; Alicia Cho; Ashley Emery; Elizabeth R Gilbert; Zhiyong Cheng
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne.

Authors:  Bodo C Melnik; Christos C Zouboulis
Journal:  Exp Dermatol       Date:  2013-05       Impact factor: 3.960

Review 10.  Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link.

Authors:  Zhiyong Cheng; Fabio A Almeida
Journal:  Cell Cycle       Date:  2014-02-12       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.